CRITICAL THERAPY ANTIDOTE LIMITEDActive
Key figures
CRITICAL THERAPY ANTIDOTE LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2024/25Balance sheet structure
Filed accounts2023/24–2024/25
| 2023/24 | 2024/25 | |
|---|---|---|
| Profit for the year | 1,551 | 4,370 |
| Cash at bank and in hand | 2,449 | 5,906 |
| Total assets | 2,449 | 5,906 |
| Total liabilities | 898 | 280 |
| Net assets / total equity | 1,551 | 5,626 |
| Average number of employees | 0 | 0 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025Critical Theory Antidote is a professional membership organisation for mental health practitioners which provides support, talks and training.
As described in the company's latest filed accounts.
Summary: CRITICAL THERAPY ANTIDOTE LIMITED
Company
CRITICAL THERAPY ANTIDOTE LIMITED is a private company limited by guarantee registered with Companies House under company number 14964403. It was incorporated on 27 Jun 2023. Its status is active. The registered office is in London (W6). Its nature of business (SIC 2007) is other human health activities (86900), activities of other membership organizations n.e.c. (94990).
Accounts
The latest accounts in the database are for 2024/25 (period ending 30 Jun 2025); the company files abridged accounts (unaudited). Profit for the year was £4,370. Net assets were £5,626, up 262.7% on the previous year. Cash at bank and in hand was £5,906. Total assets were £5,906 and total liabilities £280. The company had an average of 0 employees. Figures are available for 2 financial years (2023/24–2024/25).
Control and charges
2 persons with significant control are registered.
Filing deadlines
The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 10 Jul 2027.